Literature DB >> 9419179

Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock.

L Liaudet1, A Rosselet, M D Schaller, M Markert, C Perret, F Feihl.   

Abstract

The effects of two nitric oxide synthase (NOS) inhibitors with different isoform selectivity were compared in a murine model of endotoxemia. Mice challenged with 70 mg/kg intraperitoneal (ip) lipopolysaccharide (LPS) were treated 6 h after LPS with either NG-gamma-L-arginine methyl ester (L-NAME, nonselective NOS inhibitor, 10-60 mg/kg), L-canavanine (selective inhibitor of inducible NOS, 50-300 mg/kg), or saline (0.2 mL) given ip. In a subset of mice, plasma concentrations of nitrate (NO breakdown product), lipase (pancreas injury), lactate dehydrogenase, and transaminases (liver injury) were measured 16 h after LPS. Although both inhibitors reduced plasma nitrate, they produced contrasting effects on survival and organ injury. L-NAME enhanced liver damage and tended to accelerate the time of death, while L-canavanine significantly reduced mortality and had no deleterious effects in terms of organ damage. These results indicate that nonselective NOS inhibitors are detrimental in endotoxic shock and support the potential usefulness of selective inducible NOS inhibitors in this setting.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9419179     DOI: 10.1086/513813

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Inducible nitric oxide synthase inhibition improves intestinal microcirculatory oxygenation and CO2 balance during endotoxemia in pigs.

Authors:  Martin Siegemund; Jasper van Bommel; Lothar A Schwarte; Wolfgang Studer; Thierry Girard; Stephan Marsch; Peter Radermacher; Can Ince
Journal:  Intensive Care Med       Date:  2005-06-15       Impact factor: 17.440

2.  Comparison of the effects of vasopressin and norepinephrine on organ perfusion during septic shock in streptozotocin-induced diabetic rats.

Authors:  Hiroshi Hinohara; Yuji Kadoi; Aya Tokue; Shigeru Saito; Chikara Kawauchi; Akio Mizutani
Journal:  J Anesth       Date:  2010-08       Impact factor: 2.078

Review 3.  The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis.

Authors:  James Leiper; Manasi Nandi
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

4.  The relationship between transient zinc ion fluctuations and redox signaling in the pathways of secondary cellular injury: relevance to traumatic brain injury.

Authors:  Yuan Li; Bridget E Hawkins; Douglas S DeWitt; Donald S Prough; Wolfgang Maret
Journal:  Brain Res       Date:  2010-03-18       Impact factor: 3.252

5.  Effect of combining nicotinamide as a PARS-inhibitor with selective iNOS blockade during porcine endotoxemia.

Authors:  A Stehr; F Ploner; I Tugtekin; M Matejovic; M Theisen; C Zülke; M Georgieff; P Radermacher; K-W Jauch
Journal:  Intensive Care Med       Date:  2003-05-09       Impact factor: 17.440

Review 6.  [Pathomechanisms of organ failure. Mitochondrial dysfunction in sepsis].

Authors:  M Wendel; A R Heller; T Koch
Journal:  Anaesthesist       Date:  2009-04       Impact factor: 1.041

7.  Potent anti-inflammatory effects of two quinolinedione compounds, OQ1 and OQ21, mediated by dual inhibition of inducible NO synthase and cyclooxygenase-2.

Authors:  Kyung-Min Lim; Joo-Young Lee; Song-Mi Lee; Ok-Nam Bae; Ji-Yoon Noh; Eun-Jin Kim; Seung-Min Chung; Jin-Ho Chung
Journal:  Br J Pharmacol       Date:  2009-01-19       Impact factor: 8.739

8.  Is There NO Treatment For Severe Sepsis?

Authors:  Bredan As; Cauwels A
Journal:  Libyan J Med       Date:  2008-03-01       Impact factor: 1.657

9.  Aciculatin inhibits lipopolysaccharide-mediated inducible nitric oxide synthase and cyclooxygenase-2 expression via suppressing NF-κB and JNK/p38 MAPK activation pathways.

Authors:  I-Ni Hsieh; Anita Shin-Yuan Chang; Che-Ming Teng; Chien-Chih Chen; Chia-Ron Yang
Journal:  J Biomed Sci       Date:  2011-05-06       Impact factor: 8.410

Review 10.  Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure.

Authors:  Alessandro Protti; Mervyn Singer
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.